Evidence map›Paper›PMID 37810872›Full record

ArticleHeliyon2023

Quantitative tumor burden imaging parameters of the spleen at MRI for predicting treatment response in patients with acute leukemia.

Wenjin Bian, Jianling Zhang, Qianqian Huang, Weiran Niu, Jianting Li, Xiaoli Song, Sha Cui, Qian Zheng, Jinliang Niu, Xiaohong Joe Zhou

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Wenjin BianDepartment of Medical Imaging, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Jianling ZhangDepartment of Medical Imaging, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Qianqian HuangDepartment of Medical Imaging, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Weiran NiuDepartment of Mental Health, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Jianting LiDepartment of Radiology, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Xiaoli SongDepartment of Radiology, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Sha CuiDepartment of Radiology, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Qian ZhengDepartment of Medical Imaging, Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Jinliang NiuDepartment of Radiology, The Second Hospital of Shanxi Medical University, Taiyuan, 030001, Shanxi, China.
Xiaohong Joe ZhouCenter for MR Research and Departments of Radiology, Neurosurgery, And Biomedical Engineering, University of Illinois at Chicago, Chicago, 60612, Illinois, USA.
Shanxi Medical University · CNUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To study the value of standardized volume and intravoxel incoherent motion (IVIM) parameters of the spleen based on tumor burden for predicting treatment response in newly diagnosed acute leukemia (AL). Methods: Patients with newly diagnosed AL were recruited and underwent abdominal IVIM diffusion-weighted imaging within one week before the first induction chemotherapy. Quantitative parameters of magnetic resonance imaging (MRI) included the standardized volume (representing volumetric tumor burden) and IVIM parameters (standard apparent diffusion coefficient [sADC]; pure diffusion coefficient [ Results: 76 AL patients (CR: n = 43; non-CR: n = 33) were evaluated. Standardized spleen volume, sADC, Conclusion: Standardized volume,

Indexed as

Acute leukemiaIntravoxel incoherent motion (IVIM)SpleenTreatment responseTumor burden

Identifiers

PMID37810872
PMCPMC10550618
OpenAlexW4386879842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.